Expert Video - What new treatments are in development for AML?
Acute myeloid leukemia (AML) expert Dr. David Steensma describes encouraging developments in treating AML. This includes the FDA approval of eight new treatments in the past few years and the many clinical trials under way for AML. Medications that target specific mutations responsible for AML are also available as targeted therapy. Some of these target the bone marrow environment where AML cells develop. New chemotherapy drugs for AML are also being developed.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.